Moderna’s RSV Shot Wins FDA Approval for Use in Older Adults

  • 📰 BNNBloomberg
  • ⏱ Reading Time:
  • 26 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 14%
  • Publisher: 50%

Business Business Headlines News

Business Business Latest News,Business Business Headlines

Moderna Inc. gained US approval for its RSV vaccine in older adults, giving the biotech a second product as it seeks to move beyond its reliance on the fading Covid-19 market.

Moderna’s RSV Shot Wins FDA Approval for Use in Older AdultsTexas Utility Stock Powers Past Nvidia in 300% AI-Fueled RallySouth Africa’s Shock Election Imperils Business-Driven ReformsUBS Completes Historic Takeover as Credit Suisse Ceases to ExistSoftware Blowups Sow Fears That AI Boom Is Leaving Some BehindDell’s $3.

Fed minutes show officials rally around higher-for-longer ratesFreeland says capital gains proposal will be tabled before summer breakSouth African President’s Allies Want Democratic Alliance DealYemen’s Houthis Say US and UK Have Carried Out Deadliest StrikeANC Loses Its Outright Majority in South Africa’s Northern CapeLithuania Can Train Troops in Ukraine If Needed, Premier SaysIndia’s Holy City Set to Bless Modi With a Third Straight Win in ElectionsChina Home Sales Slump Eases After New...

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 83. in BUSİNESS

Business Business Latest News, Business Business Headlines